LATOYA NEWTON: Open Payments
NPI 1437813144 · SAGINAW, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,274 in 52 payments from 13 companies in 2025. Trend: 2023 $1,497 · 2024 $1,941 · 2025 $1,274
Food & beverage: $1,274
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $710 |
| PFIZER INC. | 5 | $80 |
| Lundbeck LLC | 2 | $75 |
| Otsuka America Pharmaceutical, Inc. | 3 | $64 |
| UCB, Inc. | 2 | $54 |
| Lilly USA, LLC | 2 | $49 |
| Eisai Inc. | 2 | $47 |
| Aucta Pharmaceuticals, Inc. | 2 | $47 |
| AstraZeneca Pharmaceuticals LP | 2 | $42 |
| JAZZ PHARMACEUTICALS INC. | 2 | $40 |
Products named: QULIPTA, NURTEC ODT, VYEPTI, REXULTI, UBRELVY, Leqembi, Motpoly XR, WAINUA.
Industry payments across MI — which companies pay providers there.
